Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1976 Mar 6;1(6009):550–553. doi: 10.1136/bmj.1.6009.550

Streptokinase in central retinal vein occlusion: a controlled clinical trial.

E M Kohner, J E Pettit, A M Hamilton, C J Bulpitt, C T Dollery
PMCID: PMC1639322  PMID: 769891

Abstract

Forty patients with central retinal vein occlusion were allocated at random either to a treatment group given streptokinase followed by anticoagulatns or to a control group given no specific treatment. The two groups, which were each of 20 patients, were broadly similar in respect of clinical and laboratory values and similar in their initial visual acuity. At follow-up ("final" vision) the visual acuity in the treated group was significantly better than in the untreated group. Only one treated patient developed thrombotic glaucoma compared with four controls. Streptokinase may, however, have been responsible for vitreous haemorrhage (and permanent loss of vision) in three patients and hence probably has only a limited role in the treatment of central retinal vein occlusion.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The mechanism of clot dissolution by plasmin. J Clin Invest. 1959 Jul;38(7):1086–1095. doi: 10.1172/JCI103885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hiemeyer V. Thrombolytische Therapie bei akuten Gefässverschlüssen. Dtsch Med Wochenschr. 1967 May 26;92(21):955–959. doi: 10.1055/s-0028-1103727. [DOI] [PubMed] [Google Scholar]
  3. Joplin G. F., Oakley N. W., Hill D. W., Kohner E. M., Fraser T. R. Diabetic retinopathy. II. Comparison of disease remission induced by various degrees of pituitary ablation by Y90. Diabetologia. 1967 Aug;3(4):406–412. doi: 10.1007/BF02342634. [DOI] [PubMed] [Google Scholar]
  4. KLIEN B. A., OLWIN J. H. A survey of the pathogenesis of retinal venous occlusion, emphasis upon choice of therapy and an analysis of the therapeutic results in fifty-three patients. AMA Arch Ophthalmol. 1956 Aug;56(2):207–247. [PubMed] [Google Scholar]
  5. Merskey C., Kleiner G. J., Johnson A. J. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. Blood. 1966 Jul;28(1):1–18. [PubMed] [Google Scholar]
  6. OGSTON D., FULLERTON H. W. Changes in fibrinolytic activity produced by physical activity. Lancet. 1961 Sep 30;2(7205):730–733. doi: 10.1016/s0140-6736(61)90685-7. [DOI] [PubMed] [Google Scholar]
  7. RATNOFF O. D., MENZIE C. A new method for the determination of fibrinogen in small samples of plasma. J Lab Clin Med. 1951 Feb;37(2):316–320. [PubMed] [Google Scholar]
  8. VANNAS S., ORMA H. Experience of treating retinal venous occlusion with anticoagulant and antisclerosis therapy. AMA Arch Ophthalmol. 1957 Dec;58(6):812–828. doi: 10.1001/archopht.1957.00940010834004. [DOI] [PubMed] [Google Scholar]
  9. den Ottolander G. J., Craandijk A. Treatment of thrombosis of the central retinal vein with streptokinase. Thromb Diath Haemorrh. 1968 Dec 31;20(3):415–419. [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES